Cannabis in the US

Cannabis in the US

Cannabis in the US has seen a significant slowdown in growth in recent years, albeit with a still positive performance, and showing many indications of more robust growth over the forecast period. Although near-term federal legalisation is less likely, since it has not been a priority of the current administration, sales of cannabis in the US continue to expand as a result of organic growth, as social acceptance and new users continue to increase, as well as the expansion of state legalisation i...

Euromonitor International's Cannabis in USA market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2028 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD & Other Non-Intoxicating Cannabinoids, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.